Suchergebnisse - "Anderson, Colleen"

PubPharm (6)

1

Randomized, double-blind, controlled trial of human anti-LIGHT monoclonal antibody in COVID-19 acute respiratory distress syndrome

enthalten in: The Journal of clinical investigation | 2022

von Perlin, D. | Neil, G. | Anderson, C. | +4

2

Maintenance of efficacy of lisdexamfetamine dimesylate in children and adolescents with attention-deficit/hyperactivity disorder : randomized-withdrawal study design

enthalten in: Journal of the American Academy of Child and Adolescent Psychiatry | 2014

von Coghill, D. | Banaschewski, T. | Lecendreux, M. | +9

3

Lisdexamfetamine dimesylate augmentation in adults with persistent executive dysfunction after partial or full remission of major depressive disorder

enthalten in: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology | 2014

von Madhoo, M. | Keefe, R. | Roth, R. | +5

4

European, randomized, phase 3 study of lisdexamfetamine dimesylate in children and adolescents with attention-deficit/hyperactivity disorder

enthalten in: European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology | 2013

von Coghill, D. | Banaschewski, T. | Lecendreux, M. | +8

5

A post hoc comparison of the effects of lisdexamfetamine dimesylate and osmotic-release oral system methylphenidate on symptoms of attention-deficit hyperactivity disorder in children and adolescents

enthalten in: CNS drugs | 2013

von Soutullo, C. | Banaschewski, T. | Lecendreux, M. | +8

6

Attention-deficit/hyperactivity disorder-specific quality of life with triple-bead mixed amphetamine salts (SPD465) in adults : results of a randomized, double-blind, placebo-controlled study

enthalten in: The Journal of clinical psychiatry | 2008

von Spencer, T. | Landgraf, J. | Adler, L. | +3

1
[1]